SCHEMBL5316533

SCHEMBL5316533

NCC1CCN(C[C@H]2CCOC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.41
CXCR4 P61073 1/20 0.36
NAMPT P43490 3/20 0.35
HTR4 Q13639 1/20 0.33
HSD11B1 P28845 1/20 0.33
TLR9 Q9NR96 1/20 0.33
TLR8 Q9NR97 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
MGLL Q99685 1/20 0.33
ACHE P22303 1/20 0.32
CHRM5 P08912 1/20 0.32
ADRA2C P18825 1/20 0.32
GBA1 P04062 1/20 0.32
UBE2M P61081 1/20 0.31
DCUN1D1 Q96GG9 1/20 0.31
MLNR O43193 1/20 0.31
CYP11B2 P19099 1/20 0.30
PIK3CD O00329 1/20 0.30
PIK3R2 O00459 1/20 0.30
PIK3CA P42336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5315253 1.00 NCF1 (0.41) NCF1CXCR4NAMPTHTR4HSD11B1
SCHEMBL416372 0.89 NCF1 (0.43) NCF1CXCR4HTR4ACHECHRM5
Hydrochloric Acid SCHEMBL5314906 0.87 NCF1 (0.42) NCF1CXCR4HTR4ACHECHRM5
SCHEMBL7226560 0.83 NAMPT (0.36) NAMPTHTR4HSD11B1TLR9TLR8
SCHEMBL5012467 0.83 NAMPT (0.36) NAMPTHTR4HSD11B1TLR9TLR8
SCHEMBL12671 0.80 CHRM5 (0.52) NAMPTHTR4HSD11B1TLR9TLR8
SCHEMBL8261146 0.79 ACHE (0.55) NAMPTHTR4HSD11B1TLR9TLR8
SCHEMBL13220 0.79 ADRA2C (0.56) NAMPTHTR4HSD11B1MGLLACHE
SCHEMBL23015324 0.78 NCF1 (0.52) NCF1CXCR4ACHECHRM5ADRA2C
SCHEMBL470130 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007068739-A1 4-AMINO-BENZAMIDE DERIVATIVES AS 5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL, NEUROLOGICAL AND CARDIOVASCULAR DISORDERS GLAXO GROUP LIMITED (GB) 2007-06-21 WO disclosed